Physician profile
Haley Lanser
NPI 1194384503
$1,870.76
in general payments reported to CMS, 2019-2025
9 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.93 · 2024: $746 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.36 |
| Education | $181.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $436.24 | 2024-2025 | Gore Enform Preperitoneal Biomaterial, Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Baxter Healthcare | $364.38 | 2024-2025 | Perclot, Seprafilm, Tisseel |
| Medtronic, INC. | $330.59 | 2025 | Endo Gia Ultra, Signia |
| Boston Scientific Corporation | $231.24 | 2024-2025 | Apollo Esg Nxt System, Overstitch Endoscopic Suturing System |
| Ethicon US, LLC | $138.41 | 2025 | Smartablatetm System Rf Generator, Echelon Flex |
| Integra Lifesciences Corporation | $138.24 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $119.94 | 2025 | Exparel |
| Davol INC. | $91.79 | 2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $19.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Lanser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.